Issue link: http://osercommunicationsgroup.uberflip.com/i/365683
C h a i n D ru g s to re D a i l y M o n d a y, Au g u s t 2 5 , 2 0 1 4 4 Been waiting to hear exciting health food product news through the grapevine? If so, Crunchies ® – the leading producer of all-natural freeze-dried vegetable and fruit snacks in the country – has a tasty announcement: the addition this year of all-natural Grapes to its popular Grab-n- Go fruit line. Delectable red grapes, long a favorite of young and old alike, are now easily packed into even the fullest back- pack, whether for school, play, sports or a hike. But that's not all: you have to taste Grapes to believe how flavorful freeze- dried fruit can be! Plus, they retain the fruit's shape! Grapes join Crunchies' newest veg- gies, Buttered Sweet Corn and BBQ Roasted Veggies, which were introduced to Crunchies' Grab-n-Go family in 2013. With such a palate-pleasing variety sure to match every taste, consumers can now crunch even more favorite vegetables and fruit in single snacks every bit as healthy and convenient as they are deli- cious. Grab-n-Go bags range from 1 ounce to 3.25 ounces with an MSRP of $5.29 to 5.69. Select Crunchies' varieties are also available in single-serve Munch Paks, 0.33 ounces, with an MSRP of $1.29 to $1.79. Like all Crunchies' products, Grapes are made in the U.S.A. through a unique freeze- drying process in which individually frozen grapes are placed in a refrigerated vacuum chamber that removes up to 97 percent of the moisture. This special process gives Crunchies their namesake crunchy tex- ture and allows them to retain a high per- centage of the nutritious enzymes that are invariably lost through traditional heat drying. Veggie Crunchies are not only incredibly wholesome, but are also rich in fiber, protein and isoflavones. Each delicious flavor contains relatively little CRUNCHIES INTRODUCES GRAB-N-GO GRAPES Camber Pharmaceuticals, a rapidly grow- ing generics manufacturer, has added an additional 20,000 square feet of office and warehouse space to its Piscataway, N.J. facility, bringing its total to 86,000 square feet. "The additional space is necessary as we introduce new products and add key staff members throughout the organiza- tion to meet the increasing demands of our customers," said Kon Ostaficiuk, President of Camber Pharmaceuticals. "Our goal is to be the most reliable and affordable generic supplier across a broad range of therapeutic classes." From API to Finished Dosage, Camber Delivers Camber Pharmaceuticals is a wholly owned subsidiary of Hetero Drugs based in Hyderabad, India. Hetero Drugs is a pharmaceutical, research and develop- ment company that has emphasis on API production and the manufacturing of fin- ished dosage forms. Hetero currently manu- factures and markets more than 200 products and has a robust pipeline. Its state-of-the-art facilities include four FDA-approved sites for API, three FDA-approved sites for finished goods, more than 100 DMFs filed, and facilities and joint ventures in India, the United States, South America, Europe and the Middle East. Camber's associate company, Invagen Pharmaceuticals, Inc. – located in Hauppauge, N.Y. – focuses CAMBER ADDS FACILITIES AS IT CONTINUES IMPRESSIVE GROWTH Continued on Page 61 Continued on Page 61 Lee M. Oser CEO and Editor-in-Chief Kim Forrester Paul Harris Associate Publishers Lorrie Baumann Editorial Director Jeanie Catron JoEllen Lowry Dave Bernard Associate Editors Yasmine Brown Vicky Glover Graphic Designers Ruth Haltiwanger Customer Service Manager Lynn Hilton Conda Peeler Justin Schmigel Account Managers Enrico Cecchi European Sales Chain Drugstore Daily is published by Oser Communications Group ©2014 All rights reserved. Executive and editorial offices at: 1877 N. Kolb Road, Tucson, AZ 85715 520.721.1300/Fax: 520.721.6300 www.oser.com European offices located at Lungarno Benvenuto Cellini, 11, 50125 Florence, Italy. AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS